Literature DB >> 22436109

Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making.

Julien Mancini1, Dominique Genre, Florence Dalenc, Jean-Marc Ferrero, Pierre Kerbrat, Anne-Laure Martin, Henri Roché, Françoise Maylevin, Carole Tarpin, Patrice Viens, Corinne Gamet, Claire Julian-Reynier.   

Abstract

OBJECTIVE: To identify the factors associated with long-term regrets expressed a posteriori by randomized controlled trial (RCT) participants questioned about their decision to participate in an RCT. STUDY DESIGN AND
SETTING: Participants were questioned 6 years on average after their inclusion in a breast cancer adjuvant therapy RCT. Among 115 women from 21 centers, 93 (81%) answered a self-administered questionnaire based on the Decision Regret Scale (DRS).
RESULTS: Mean DRS score was 16.8 (standard deviation=15.9); 43.0% of participants expressed mild regret, and 25.8% expressed moderate to strong regret. A quarter of the women (25.6%) said that the decision was taken by the doctor alone, and 13.5% said it was not consistent with their own wishes. In the multivariate ordinal regression analysis, an involuntarily passive role in decision making was found to be associated with greater regret (cumulative proportional odds ratio=7.3, 95% confidence interval=2.0-27.6), regardless of age and being allotted or not to the standard treatment in the RCT.
CONCLUSION: Whether patients' regret depended on their level of participation in the decision making or vice versa could not be determined in this cross-sectional survey, but efforts should be made to ensure that patients' participation in trials is always based on an active personal decision.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22436109     DOI: 10.1016/j.jclinepi.2011.12.003

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Spirituality is associated with less treatment regret in men with localized prostate cancer.

Authors:  Michelle A Mollica; Willie Underwood; Gregory G Homish; D Lynn Homish; Heather Orom
Journal:  Psychooncology       Date:  2016-09-15       Impact factor: 3.894

2.  Factors associated with enrolment in clinical trials among women with early-stage breast cancer.

Authors:  D Presti; J Havas; D Soldato; P Lapidari; E Martin; B Pistilli; C Jouannaud; G Emile; O Rigal; M Fournier; P Soulie; M-A Mouret-Reynier; C Tarpin; M Campone; S Guillermet; A-L Martin; S Everhard; A Di Meglio
Journal:  ESMO Open       Date:  2022-06-17

3.  What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.

Authors:  Heather Orom; Caitlin Biddle; Willie Underwood; Christian J Nelson; D Lynn Homish
Journal:  Med Decis Making       Date:  2016-03-08       Impact factor: 2.583

4.  More primary care patients regret health decisions if they experienced decisional conflict in the consultation: a secondary analysis of a multicenter descriptive study.

Authors:  Maria-Margarita Becerra-Perez; Matthew Menear; Stephane Turcotte; Michel Labrecque; France Légaré
Journal:  BMC Fam Pract       Date:  2016-11-10       Impact factor: 2.497

5.  Shared decision-making and the lessons learned about decision regret in cancer patients.

Authors:  Mariam Chichua; Eleonora Brivio; Davide Mazzoni; Gabriella Pravettoni
Journal:  Support Care Cancer       Date:  2022-01-15       Impact factor: 3.359

6.  Women's Experiences with Deciding on Neoadjuvant Systemic Therapy for Operable Breast Cancer: A Qualitative Study.

Authors:  Anne Herrmann; Alix Hall; Nicholas Zdenkowski
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.